Upgrade to SI Premium - Free Trial

Bio-Rad Labs (BIO)

386.11 -1.79 (0.46%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/22/26)

Latest Headlines

Form 4 BIO-RAD LABORATORIES, For: Sep 01 Filed by: BARRY JAMES September 3, 2026 5:41 PM - SEC Filing Form 4 BIO-RAD LABORATORIES, For: Sep 01 Filed by: Allison Schwartz September 3, 2026 5:39 PM - SEC Filing Form 4 BIO-RAD LABORATORIES, For: Sep 01 Filed by: SCHWARTZ NORMAN D September 3, 2026 5:36 PM - SEC Filing Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference August 31, 2026 9:00 AM - BizWire iMDx posts Q2 loss as FDA review of GraftAssureDx continues August 10, 2026 4:07 PM - StreetInsider IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx August 10, 2026 4:05 PM - Globe NewsWire Bio-Rad Labs (BIO) PT Raised to $330 at Wells Fargo August 5, 2026 7:58 AM - StreetInsider Bio-Rad Labs (BIO) PT Raised to $370 at RBC Capital August 5, 2026 7:44 AM - StreetInsider Bio-Rad Labs (BIO) Tops Q2 EPS by 81c; offers outlook August 4, 2026 5:30 PM - StreetInsider Form 10-Q BIO-RAD LABORATORIES, For: Jun 30 August 4, 2026 4:21 PM - SEC Filing Form 8-K BIO-RAD LABORATORIES, For: Jul 31 August 4, 2026 4:17 PM - SEC Filing Bio-Rad Reports Second-Quarter 2026 Financial Results August 4, 2026 4:15 PM - BizWire Form 4 BIO-RAD LABORATORIES, For: Jul 25 Filed by: ENGELHARDT EVA ANETTE July 28, 2026 3:06 PM - SEC Filing Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026 July 23, 2026 9:00 AM - BizWire Full Article List